WisdomTree Europe Domestic Economy Fund EDOM 深 沪
已收盘 03-15 16:00:00 美东时间
24.346
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 24.346
- 总市值 487.00万
- 52周最高 30.2431
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 21.13
- 委 比 0.00%
- 总股本 20.00万
- 历史最高 32.2711
- 量 比 0
- 振 幅 0.00%
- 历史最低 21.13
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Is PepGen Stock Sinking Tuesday?
PepGen stock drops after Phase 2 low-dose data show limited splicing correction; higher-dose cohorts and FDA hold remain key focus areas.
03-31 19:14
PepGen Announces Clinical Data From The 5 Mg/Kg Multiple Ascending Dose Cohort Of The Ongoing Phase 2 FREEDOM2-DM1 Trial In Patients With Myotonic Dystrophy Type 1; PGN-EDOM1 Was Generally Well-Tolerated With All Adverse Events Mild Or Moderate And No Serious Adverse Events Reported
PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases,
03-31 04:14
Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Dow futures up 1000 points. Valneva stock falls in pre-market. Pfizer and Valneva announce Phase 3 results for Lyme disease vaccine. Other stocks also down.
03-23 20:03
Trump Administration Sues Gavin Newsom's California Over Emissions Goals, Sean Duffy Decries 'Illegal EV Mandate'
Trump administration sues California over emissions goals; DOT says state-specific mileage requirements are illegal.
03-13 13:44
BRIEF-Titomic Announces Plans To Redomicile To United States
BRIEF-Titomic Announces Plans To Redomicile To United States March 12 (Reuters) - Titomic Ltd TTT.AX : ANNOUNCES PLANS TO REDOMICILE TO UNITED STATES Further company coverage: TTT.AX (( Reuters.Briefs@thomsonreuters.com ;))
03-12 08:25
PepGen Inc. FREEDOM2 Trial Placed On Partial FDA Hold Related To Preclinical Pharmacology And Toxicology; Cleared To Proceed In South Korea, Australia, And New Zealand And Dosing Of The 10 mg/kg Cohort Continues In The UK And Canada; Data Expected In 2026
- U.S. FDA places FREEDOM2 trial on partial clinical hold related to preclinical pharmacology and toxicology -- Received regulatory clearance to initiate FREEDOM2 in South Korea, Australia, and New Zealand and dosing of
03-05 05:13
BRIEF-Honda Is Recalling 65,135 U.S. Vehicles As Instrument Panel and Rearview Camera Displays May Fail - NHTSA
BRIEF-Honda Is Recalling 65,135 U.S. Vehicles As Instrument Panel and Rearview Camera Displays May Fail - NHTSA March 4 (Reuters) - HONDA (AMERICAN HONDA MOTOR CO.) IS RECALLING 65,135 U.S. VEHICLES - NHTSA HONDA (AMERICAN HONDA MOTOR CO.) IS RECALLING SOME U.S. VEHICLES AS AN INSTRUMENT PANEL DISPL
03-04 16:13
BRIEF-Nova Minerals Executes Scheme Implementation Deed
BRIEF-Nova Minerals Executes Scheme Implementation Deed March 3 (Reuters) - Nova Minerals Ltd NVA.AX : EXECUTES SCHEME IMPLEMENTATION DEED FOR US REDOMICILIATION Further company coverage: NVA.AX (( Reuters.Briefs@thomsonreuters.com ;))
03-03 09:35
PepGen’s FREEDOM-DM1 Trial Reaches Early Safety Milestone for Myotonic Dystrophy
PepGen Inc. ($PEPG) announced an update on their ongoing clinical study. PepGen...
02-14 00:30
BRIEF-Freedom Holding Reports Third Quarter Fiscal Year 2026 Financial Results
BRIEF-Freedom Holding Reports Third Quarter Fiscal Year 2026 Financial Results Feb 9 (Reuters) - Freedom Holding Corp FRHC_KZ.KZ : FREEDOM HOLDING CORP. REPORTS THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS FREEDOM HOLDING CORP - Q3 TOTAL REVENUE $628.6 MILLION FREEDOM HOLDING CORP - DILUTED EPS
02-10 06:01
